Sanofi Collaborates with Aetion to Leverage its Evidence Platform for Advancing Regulatory Submissions

Sanofi Collaborates with Aetion to Leverage its Evidence Platform for Advancing Regulatory Submissions

Shots:

  • Sanofi is launching an enterprise-wide project to assimilate its real-world data platform, DARWIN with the Aetion’s Evidence Platform for advancing the efficient use of real-world evidence to facilitate regulatory-grade studies with deep transparency while opening access to new real-world data
  • The collaboration will lead to the transformation of the health care ecosystem following the FDA’s prioritizing efforts to incorporate RWE as a companion to clinical studies data, aiding in regulatory decision making. The US FDA intends to release its draft RWE guidance before the end of 2020
  • Sanofi’s Darwin is designed to compile and analyze de-identified data, while the Aetion’s Evidence platform analyzes real-world data to expose answers about the effectiveness, safety and value of drugs

Click here to­ read full press release/ article | Ref: Sanofi | Image: Reuters